Our results add to the complexity of this relationship, as methylation of the promoter of miR-29c in basal-like breast cancer can decrease miR-29c expression, and, therefore, cause deregulation and over-expression of DNMT3b. This evidence concerns the gene DNMT3B and breast carcinoma.